These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27170209)

  • 1. Glial progenitor cell-based treatment of the childhood leukodystrophies.
    Osorio MJ; Goldman SA
    Exp Neurol; 2016 Sep; 283(Pt B):476-88. PubMed ID: 27170209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progenitor cell-based treatment of glial disease.
    Goldman SA
    Prog Brain Res; 2017; 231():165-189. PubMed ID: 28554396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell-based strategies for treating pediatric disorders of myelin.
    Goldman SA; Schanz S; Windrem MS
    Hum Mol Genet; 2008 Apr; 17(R1):R76-83. PubMed ID: 18632701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial progenitor-based repair of demyelinating neurological diseases.
    Keyoung HM; Goldman SA
    Neurosurg Clin N Am; 2007 Jan; 18(1):93-104, x. PubMed ID: 17244557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure to achieve remyelination of demyelinated rat axons following transplantation of glial cells obtained from the adult human brain.
    Targett MP; Sussman J; Scolding N; O'Leary MT; Compston DA; Blakemore WF
    Neuropathol Appl Neurobiol; 1996 Jun; 22(3):199-206. PubMed ID: 8804021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progenitor cell-based treatment of the pediatric myelin disorders.
    Goldman SA
    Arch Neurol; 2011 Jul; 68(7):848-56. PubMed ID: 21403006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to make an oligodendrocyte.
    Goldman SA; Kuypers NJ
    Development; 2015 Dec; 142(23):3983-95. PubMed ID: 26628089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Replacement Therapy Improves Pathological Hallmarks in a Mouse Model of Leukodystrophy Vanishing White Matter.
    Dooves S; Leferink PS; Krabbenborg S; Breeuwsma N; Bots S; Hillen AEJ; Jacobs G; van der Knaap MS; Heine VM
    Stem Cell Reports; 2019 Mar; 12(3):441-450. PubMed ID: 30799272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remyelination: cellular and gene therapy.
    Billinghurst LL; Taylor RM; Snyder EY
    Semin Pediatr Neurol; 1998 Sep; 5(3):211-28. PubMed ID: 9777679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial progenitor cell-based repair of the dysmyelinated brain: Progression to the clinic.
    Goldman SA; Mariani JN; Madsen PM
    Semin Cell Dev Biol; 2021 Aug; 116():62-70. PubMed ID: 33414060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms.
    van der Knaap MS; Bugiani M
    Acta Neuropathol; 2017 Sep; 134(3):351-382. PubMed ID: 28638987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of oligodendrocyte progenitor cells in animal models of leukodystrophies.
    Kondo Y; Duncan ID
    Methods Mol Biol; 2009; 549():175-85. PubMed ID: 19378203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial cells in the driver seat of leukodystrophy pathogenesis.
    Garcia LM; Hacker JL; Sase S; Adang L; Almad A
    Neurobiol Dis; 2020 Dec; 146():105087. PubMed ID: 32977022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial progenitor cell-based treatment and modeling of neurological disease.
    Goldman SA; Nedergaard M; Windrem MS
    Science; 2012 Oct; 338(6106):491-5. PubMed ID: 23112326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial progenitor cell transplantation and the generation of chimeric animal models with human brain cells: implications for novel therapeutics.
    Munoz-Sanjuan I
    Expert Opin Ther Pat; 2009 Dec; 19(12):1639-46. PubMed ID: 19939186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astroglia in Leukodystrophies.
    Jorge MS; Bugiani M
    Adv Exp Med Biol; 2019; 1175():199-225. PubMed ID: 31583590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The translational biology of remyelination: past, present, and future.
    Franklin RJ; Gallo V
    Glia; 2014 Nov; 62(11):1905-15. PubMed ID: 24446279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cells and axo-glial interactions: implications for demyelinating disorders.
    Waxman SG; Black JA; Sontheimer H; Kocsis JD
    Clin Neurosci; 1994; 2(3-4):202-10. PubMed ID: 7749889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
    Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
    Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.